Table 1: Clinical Data From 5 Patients (5 Eyes) with Liquefied Aftercataract

Patient No., Age (Yrs), Sex Complications/Remarks Preoperative AL1 (mm) Intraocular lens Time to capsu lotomy (yrs) BCVA2 (LogMAR) (Pre-/Postcapsulotomy) SERE3 (D) (Pre-/Postcapsulotomy) SLA4 (µm) (Pre-/Postcapsulotomy) CLA5 (µm) (Pre-/Postcapsulotomy) Map Pattern of SLA4
1, 84, F PDR6 22.88 VA-60BB, HOYA 5.1 +0.4/+ 0.4 -0.125/-0.25 0.141/0.126 0.572/0.482 NCE†
2, 73, F Combined cataract surgery and PPV7 for BRVO8 23.70 AR40e, AMO9 5.2 +0.2/+0.2 -1.125/-0.625 0.083/0.043 0.160/0.153 NCE†
3, 75, F DM10 22.76 MA60BM, Alcon 8.2 +0.1/0 -0.675/-0.125 0.144/0.091 0.478/0.320 NCE†
4, 63, F None 25.25 VA-60BB, HOYA 4.3 +0.2/+0.1 -0.75/-1.375 0.211/0.121 0.372/0.327 PAD‡
5, 62, F PDR6 21.64 YA-60BB, HOYA 4.6 +0.2/0 -0.625/-0.875 0.165/0.109 0.318/0.257 PAD‡

Map patterns of spherical-like aberrations were categorized into the
† NCE group (those showing no capsulotomy effect)
‡ PAD group (those showing a positive spherical aberration depressed by capsulotomy)
1 AL= axial length, measured using A-scan ultrasound
2 BVCA= best-corrected visual acuity
3 SERE= spherical equivalent refractive error
4 SLA= spherical-like aberration (4-mm diameter)
5 CLA= coma-like aberration (4-mm diameter)
6 PDR= proliferative diabetic retinopathy
7 PPV= pars plana vitrectomy
8 BRVO= branch retinal vain occlusion
9 AMO=Abbott Medical Optics
10 DM= diabetes mellitus.